Lung Cancer Without Smoking: The "Other Lung Cancer" Gaining Attention Among Women and Asians

The Common Belief that "Lung Cancer = Smoker's Disease" is Being Challenged

The relationship between lung cancer and smoking is very strong.

Even now, smoking remains the biggest risk factor for lung cancer, and it's not a matter of saying "tobacco is unrelated."

However, what the medical community is increasingly focusing on is lung cancer that occurs in "never-smokers," those who have smoked little or not at all in their lifetime.

An article published by India's Deccan Chronicle on August 21, 2026, highlights the significant number of non-smokers among global lung cancer patients and introduces other factors such as air pollution, passive smoking, indoor smoke, radon, asbestos, silica, and diesel exhaust.

One of the important studies behind this is the "Sherlock-Lung" study published by the U.S. National Institutes of Health (NIH) in 2025.

The research paper states that lung cancer occurring in non-smokers accounts for about 25% of all lung cancer cases worldwide.

In other words, the image of "people who develop lung cancer = people who have smoked for many years" is becoming insufficient to fully explain the current state of lung cancer.

This change is not a distant issue for Japan either.

Rather, East Asia, including Japan, is a globally important region when considering lung cancer in non-smokers.

Investigation of Genomes of 871 Lung Cancer Patients Reveals Link to Air Pollution

In the Sherlock-Lung study published in the scientific journal "Nature" in 2025, a whole-genome analysis was conducted on tumors from 871 lung cancer patients who had never smoked, collected from 28 regions worldwide.

What drew attention here was the association with air pollution, including fine particulate matter in the atmosphere.

According to the NIH, patients in areas with high exposure to air pollution showed more mutations in TP53, a known tumor suppressor gene, and a tendency for shorter telomeres was also confirmed.

Furthermore, high exposure to air pollution was also associated with an increase in the mutation pattern known as "SBS4," previously known for its relation to smoking.

Interestingly, researchers are also investigating passive smoking.

While there was a slight tendency for a higher overall mutation count in those with passive smoking experience, this study did not confirm a strong association with specific driver gene mutations or clear mutation signatures.

However, it should not be misunderstood.

Previous epidemiological studies have shown that passive smoking increases the risk of lung cancer, and Japan's National Cancer Center states that passive smoking increases the risk of lung cancer by about 20-30%.

The results of this study do not mean "passive smoking was safe." Rather, it should be seen as indicating that lung cancer in non-smokers is too complex to be explained by a single cause.

In Japan, "Non-smoker + Lung Adenocarcinoma + EGFR" are Important Keywords

Particularly important for Japanese people is the "EGFR gene mutation."

Lung cancer is classified into several types, with lung adenocarcinoma being particularly common among Japanese.

According to the National Cancer Center, EGFR gene mutations are found in about 40% of lung adenocarcinomas among Asians, including Japanese, and are especially common in non-smokers.

Furthermore, it has long been known that lung cancer with EGFR mutations is more common in East Asia, including Japan, compared to Western countries.

In 2024, an international collaborative research team, including the National Cancer Center, conducted a large-scale analysis targeting non-smoking women in Japan, Taiwan, China, Hong Kong, Singapore, and South Korea.

Comparing genetic information from 998 lung adenocarcinoma patients and 4,544 non-smoking women without lung cancer, it was found that combinations of multiple genetic polymorphisms, or individual genetic differences, influence susceptibility to EGFR-mutant lung adenocarcinoma.

This does not mean "genetic mutations of lung cancer = hereditary diseases directly inherited from parents."

Driver gene mutations such as EGFR are essentially changes that occur within cancer cells and cannot be simply equated with so-called "cancer-prone families."

However, there are individual differences in the genetic background that influence susceptibility to lung cancer, and it is becoming apparent that these may interact with environmental factors to relate to the onset of the disease.

Over 120,000 People Diagnosed with Lung Cancer Annually in Japan

The impact of lung cancer in Japan is very significant.

According to the latest statistics from the National Cancer Center, 123,989 people were newly diagnosed with lung cancer in Japan in 2023.

Of these, 81,381 were men and 42,607 were women.

Furthermore, 75,569 people died from lung cancer in 2024.

Lung cancer remains one of the most serious diseases to consider in terms of cancer mortality in Japan.

Of course, not all of these are non-smokers. The fact that smoking is the biggest risk factor remains unchanged.

The important point is the danger of classifying oneself as unrelated to lung cancer based solely on the condition of "not smoking."

Particularly for Japanese people, given the characteristic of EGFR-mutant lung adenocarcinoma being common in non-smokers, it is important to be cautious of the assumption "I don't smoke, so I probably don't have lung cancer."

PM2.5 is Not Irrelevant Even in Japan

When hearing the word "air pollution," many might imagine regions like China or India, where severe smog is a problem.

In reality, Japan's air environment has greatly improved over the past few decades.

According to measurement results published by the Ministry of the Environment in May 2026 for the fiscal year 2024, the achievement rate of PM2.5 environmental standards was 99.5% at general air monitoring stations and 100% at automobile exhaust monitoring stations.

The annual average concentration was 8.4 micrograms per cubic meter at general stations and 8.9 micrograms at automobile exhaust stations.

Therefore, it is not appropriate to incite anxiety by saying "just living in urban areas of Japan will cause lung cancer."

However, meeting environmental standards does not equate to having zero health impact.

Exposure to air pollution varies among individuals, with differences in living environments such as proximity to busy roads, occupational exposure to dust or diesel exhaust.

Moreover, PM2.5 is not the only candidate cause for lung cancer in non-smokers.

Asbestos, silica, radon, indoor air pollution, passive smoking, pre-existing conditions, and genetic susceptibility are thought to be intricately related.

Rather than jumping to the conclusion "the culprit is PM2.5," understanding that "there are multiple pathways to lung cancer besides tobacco" is closer to current science.

The Confusion of "I've Never Smoked" Stands Out on Social Media

What makes this issue feel more personal are the voices of patients and families posted on social media and online communities.

View Posts on Reddit

The public posts reviewed this time were not limited to reactions to the Deccan Chronicle article itself but dealt with the same theme of "non-smoker lung cancer," revealing some common emotions.

On the overseas forum Reddit, a person diagnosed with lung cancer posted their confusion, stating, "I've never smoked tobacco or e-cigarettes. I don't use drugs. I'm not around smokers. Yet, I don't understand why."

In another post, a daughter expressed her anxiety about what kind of screenings she should undergo in the future after her non-smoking Asian mother was diagnosed with stage 4 non-small cell lung cancer and found to have an EGFR mutation.

A 2026 post describes a person diagnosed with non-smoker lung cancer expressing discomfort at repeatedly being asked, "But did you smoke?"

Additionally, when a scientific article on air pollution and non-smoker lung cancer was introduced on Reddit, numerous comments shared experiences of "people who never smoked getting lung cancer," and discussed air pollution, passive smoking, and genetic factors.

Of course, these social media posts are not medical statistics.

It is not possible to conclude from social media alone that "non-smoker lung cancer is rapidly increasing" or "air pollution caused this person's lung cancer."

However, there is an important issue that emerges from these posts.

It is the social image of lung cancer.

The Belief "I'm Not a Smoker, So It's Not Lung Cancer" Could Delay Discovery

A strong image of lung cancer as a "smoker's disease" can lead both the individual and those around them to downplay symptoms.

Even with a persistent cough,

"It's just a lingering cold,"

"It's probably allergies,"

"It might be asthma,"

"I don't smoke, so it can't be lung cancer,"

one might think.

The original article also lists symptoms that should not be ignored, such as a cough lasting more than three weeks, unexplained shortness of breath, chest pain, recurrent respiratory infections, hemoptysis, unexplained weight loss, severe fatigue, and hoarseness.

Of course, most of these symptoms do not mean lung cancer.

There are numerous diseases that can cause cough or shortness of breath, such as infections, asthma, and allergies.

However, if symptoms do not improve with treatment, recur frequently, are clearly worsening compared to before, or are accompanied by other abnormalities such as hemoptysis or weight loss, it is important not to exclude lung diseases solely because "I am a non-smoker."

Should All Non-Smokers Undergo CT Scans?

Here, one point to note.

Knowing the fact that "non-smokers can also have lung cancer," one might think, "Then healthy people should have CT scans every year."

However, the current scientific evaluation in Japan is not that simple.

The 2025 Lung Cancer Screening Guidelines compiled by the National Cancer Center recommend low-dose CT for heavy smokers, citing scientific evidence that it reduces lung cancer mortality.

On the other hand, performing low-dose CT on those other than heavy smokers is not recommended as a uniform measure, as the effect of reducing mortality is not yet sufficiently clear.

One reason is "overdiagnosis."

CT can detect even very small lung shadows.

As a result, it may lead to unnecessary detailed examinations and treatments for extremely slow-growing cancers that might have had little impact on health over a lifetime.

Radiation exposure, additional tests due to false positives, and mental burden must also be considered.

In Japan, from the fiscal year 2026, the Ministry of Health, Labour and Welfare is advancing a demonstration project for low-dose CT lung cancer screening, primarily targeting heavy smokers aged 50 to 74, in cities such as Otaru, Kashiwa, Yokohama, Komoro, and Iiyama.

Currently, the stage is to consider "how to introduce CT screening for high-risk individuals," and it is not a situation where "all non-smokers should regularly undergo CT."

For non-smokers, a major challenge will be narrowing down who can be identified as a high-risk group through future research.

If risk assessment combining genetic background, family history, exposure to air pollution, and medical history becomes practical, the very nature of screening could change.

In Non-Smoker Lung Cancer, "Investigating Genes" is Also Significant

Another aspect that has dramatically changed over the past decade is lung cancer treatment.

In the past, lung cancer treatment was often discussed in broad categories such as surgery, chemotherapy, and radiation.

However, today, "precision medicine," which selects treatment drugs based on genetic mutations in cancer cells, has become extremely important.

A representative example is EGFR.

In lung cancer with EGFR mutations, molecular-targeted drugs that target its function become a treatment option.

In addition, various treatment targets have been identified in lung cancer, including ALK, ROS1, BRAF, MET, RET, and KRAS.

Particularly in non-smoker lung adenocarcinoma, driver gene mutations leading to such treatments are often found.

The fact that "I got lung cancer even though I don't smoke" does not simply mean the cause is unknown.

Rather, in current medicine, the focus is shifting towards a more detailed classification of "which genetic changes are causing this cancer to proliferate."

What Japanese People Should Learn from This News

The message that Japanese people should take from the research on non-smoker lung cancer is not "anyone can suddenly get lung cancer, so be afraid."

Firstly, the fact that smoking is the largest preventable risk factor remains unchanged.

Not smoking, quitting if you already do, and avoiding passive smoking as much as possible remain important.

Secondly, the belief that "non-smokers will not get lung cancer" is also incorrect.

In East Asia, including Japan, there is EGFR-mutant lung adenocarcinoma